India’s pharmaceutical giant Cipla Ltd and consumer goods conglomerate Godrej have been recognized by Fortune magazine in a list of global firms changing the world for the good and having a positive social impact through their activities.
About Fortune Listings :-
Fortune is a multinational business magazine, published and owned by Time Inc. and headquartered in New York City. The publication was founded by Henry Luce in 1929.
- The magazine competes with Forbes and Bloomberg Business week in the national business magazine category and distinguishes itself with long, in-depth feature articles.
- The magazine is best known for the Fortune 500, a ranking of companies by revenue that it has published annually since 1955.
Fortune Change The World List :-
The Fortune 2016 ‘Change the World’ list recognizes companies that have had a positive social impact through activities that are part of their core business strategy.
- It assessed the companies on parameters of measureable social impact, business results and degree of innovation and businesses are taking on society’s biggest problems and making money doing so.
THE TOP INDUSTRIES OF THE LIST :
- Glaxo Smith Kline – Pharmaceuticals
- IDE Technologies – Industrial Machinery
- General Electric – Industrial Machinery
- Gilead Sciences – Pharmaceuticals
- Nestlé – Food Consumer Products
- Nike – Apparel
- MasterCard – Financial Data Services
- United Technologies – Aerospace & Defense
- Novozymes Specialty – Chemicals
Other notable ranking in the list are, US retail giant Walmart (15), China’s ride-sharing company Didi Chuxing (30), India-born Indra Nooyi-led PepsiCo (38), Dutch beverages giant Heineken (43) and American motor company Tesla (50).
- Cipla is ranked 46th in the list of 50 followed by Godrej on the 48th spot, the only Indian companies in the list.
- The Fortune 2016 ‘Change the World’ list recognizes companies that have had a positive social impact through activities that are part of their core business strategy.
- Cipla’s horizon is low-cost pills to fight cancer. The company is investing in a drive to create “biosimilar” versions of certain pricey oncology drugs. Expect heated intellectual-property debates—and cheaper medicines.
- Godrej’s technique “marketing a simple way to vanquish an insect enemy.” Since 2010, the company has “flooded the market with eco-friendly products, taken giant strides in a carbon neutral, zero waste, and a renewable energy effort, and imparted skills training to more than 200,000 youth from marginalized communities in 142 cities.
